InvestorsHub Logo
Followers 7
Posts 1233
Boards Moderated 0
Alias Born 09/23/2009

Re: None

Thursday, 07/17/2014 9:10:03 AM

Thursday, July 17, 2014 9:10:03 AM

Post# of 27409
Few things to discuss...

The e-mail from Dr. Chan in regards to uplisting is his typical 2 pounds of $hti in a 1 pound bag. If the only way we are going to "uplist" is to dilute the company another 25% and give away 60M shares to a bunch of institutions - then wow that sucks for us.

In regards to the publication this AM. Is anyone else realizing they don't draw ANY connections between the inflammation reduction their device does and the BENEFIT it has on patients. Yes - we all know Cytosorb reduces inflammation, IL-6 other IL's, etc. Does this mean the patients are much better off then compared to allowing the inflammation response to run its course? After all, CTSO is trying to control a natural occurence in the human body which may have a system of unknown checks and balances. Just because we reduce inflammation by 50% (just to throw a # out there) that does not mean patients are now surviving and getting out of the ICU at faster rats.

The question I am asking is:

WHAT IS THE REALIZED BENEFIT IN THE REDUCTION OF INFLAMMATION THAT CYTOSORB CAN CAUSE?[color=red][/color]

I am under the impression that ONCE AGAIN, if the data was there they would publish it. They are beating around the bush until they finally get 1 study that shows that Cytosorb does either of the following:

Helps more people survive compared to non-treated group.
Helps more people get out of the ICU or Hospital faster compared to non-treated group.
Helps to improve the outcome of surgery.

I think this will have a nice little run today. Lucky for me lol...

Thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News